Your browser doesn't support javascript.
loading
Attitudes and Behaviors with Diabetes Technology Use in the Hospital: Multicenter Survey Study in the United States.
Madhun, Nabil Z; Galindo, Rodolfo J; Donato, Jessica; Hwang, Patricia R; Shabir, Hassan F; Fowler, Michael J; Molitch-Hou, Ethan; Bena, James F; Umpierrez, Guillermo E; Lansang, M Cecilia.
Afiliación
  • Madhun NZ; Endocrinology and Metabolism Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Galindo RJ; Division of Endocrinology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Donato J; Department of Hospital Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Hwang PR; Division of Hospital Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Shabir HF; Division of Hospital Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Fowler MJ; Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Molitch-Hou E; Section of Hospital Medicine, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Bena JF; Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Umpierrez GE; Division of Endocrinology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Lansang MC; Endocrinology and Metabolism Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Diabetes Technol Ther ; 25(1): 39-49, 2023 01.
Article en En | MEDLINE | ID: mdl-36318781
Objective: To assess the attitudes, behaviors, and barriers with diabetes technology use in the general medicine hospital wards. Research Design and Methods: The authors developed a nonincentivized web-based anonymous survey that captured demographic and practice data regarding continuous subcutaneous insulin infusion (CSII) and continuous glucose monitor (CGM) use in the hospital. Setting: Four large hospital systems in the United States. Results: Among 128 survey respondents, 76%, 10%, and 6% were hospitalists, advanced practice providers, and primary care physicians, respectively. The majority of respondents rated the treatment of inpatient hyperglycemia (96%) and the continuation of CSII during the hospital stay (93%) "important." While most respondents (64%) acknowledged knowing the existence of their institution's policies for CSII use, only 84% of those respondents felt somewhat to very familiar with the policy. The most common barrier to CSII use in the inpatient setting was lack of practitioner (70%) and nursing (67%) knowledge of using the device. With regard to CGM use in the hospital, a minority (28%) of respondents were aware of their institution's CGM policies. Less than half of the providers, 43.8%, stated that, when admitting a patient, they reviewed CGM data to guide insulin dosing. Conclusions: In this US multicenter survey, we found that most inpatient practitioners valued glycemic control, but many were not familiar with institutional policies, had lack of knowledge with CSII, and were not reviewing CGM data.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipoglucemiantes Tipo de estudio: Clinical_trials / Qualitative_research Límite: Humans Idioma: En Revista: Diabetes Technol Ther Asunto de la revista: ENDOCRINOLOGIA / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipoglucemiantes Tipo de estudio: Clinical_trials / Qualitative_research Límite: Humans Idioma: En Revista: Diabetes Technol Ther Asunto de la revista: ENDOCRINOLOGIA / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos